| Literature DB >> 23070718 |
Abstract
This focused update addresses the use of the newly approved oral antiplatelet agents, prasugrel and ticagrelor, for the management of patients with UA/NSTEMI.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23070718 PMCID: PMC6652660 DOI: 10.1002/clc.22065
Source DB: PubMed Journal: Clin Cardiol ISSN: 0160-9289 Impact factor: 2.882